Pharmacological Treatment of Affective and Anxiety Disorders Flashcards
Antidepressants - mechanism
- Not fully known
- To do with the neurotransmitters serotonin and noradrenaline
- Increase levels of these in brain
- This changes receptors in the brain
Antidepressants - indications
- Unipolar and bipolar depression
- Organic mood disorders
- Schizoaffective disorder
- Anxiety disorders
- Including OCD, panic, social phobia, PTSD
Antidepressants - general guidelines
- Antidepressant efficacy is similar, so selection based on past history of response, side effect profile and coexisting medical conditions
- Delay of 2-4 weeks after therapeutic dose is achieved before symptoms improve
- If no symptoms seen after at least 2 months and adequate dose, switch to another antidepressant or augment with another agent
What is selection of antidepressant based on?
- Antidepressant efficacy is similar, so selection based on past history of response, side effect profile and coexisting medical conditions
How long do antidepressants take to work?
- Delay of 2-4 weeks after therapeutic dose is achieved before symptoms improve
- If no symptoms seen after at least 2 months and adequate dose, switch to another antidepressant or augment with another agent
What are the different classess of antidepressants?
Classification:
- Tricyclics (TCAs)
- Monoamine oxidase inhibitors (MAOIs)
- Selective serotonin reuptake inhibitors (SSRIs)
- Serotonin/noradrenaline reuptake inhibitors (SNRIs)
- Novel antidepressants
What does the following stand for:
- TCAs
- MAOIs
- SSRIs
- SNRIs
What are the 2 types of TCAs?
- Tertiary TCAs
- Have tertiary amine side chains
- These are prone to cross react with other types of receptors leading to side effects
- Drugs – Imipramine, Amitriptyline, Doxepin, Clomipramine
- Secondary TCAs
- Often metabolites of tertiary amines
- Primarily blocks noradrenaline
- Drugs – Desipramine, Notritriptyline
Mechanism of:
- tertiary TCAs
- secondary TCAs
- Tertiary TCAs
- Have tertiary amine side chains
- These are prone to cross react with other types of receptors leading to side effects
- Drugs – Imipramine, Amitriptyline, Doxepin, Clomipramine
- Secondary TCAs
- Often metabolites of tertiary amines
- Primarily blocks noradrenaline
- Drugs – Desipramine, Notritriptyline
Drugs of:
- tertiary TCAs
- secondary TCAs
- Tertiary TCAs
- Have tertiary amine side chains
- These are prone to cross react with other types of receptors leading to side effects
- Drugs – Imipramine, Amitriptyline, Doxepin, Clomipramine
- Secondary TCAs
- Often metabolites of tertiary amines
- Primarily blocks noradrenaline
- Drugs – Desipramine, Notritriptyline
Effect - TCAs
- Increases both serotonin, dopamine and noradrenaline
Side effects - TCAs
- Potentially unacceptable side effect profile
- Antihistaminic
- Anticholinergic
- Lethal in overdose
- Can cause QT lengthening
Mechanism - MAOIs
- Bind irreversible to monoamine oxidase, preventing inactivation of amines such as norepinephrine, dopamine and serotonin leading to increased synaptic levels
Indications - MAOIs
- Resistant depression
Side effects - MAOIs
- Orthostatic hypertension
- Weight gain
- Dry mouth
- Sedation
- Sexual dysfunction
- Sleep disturbance
Drug interactions - MAOIs
- Tryamine-rich foods or sympathomimetics
- Causes “cheese reaction”, which is a hypertensive crises
- Foods include cheese and red wine
- If taken with meds that increase serotonin or have sympathomimetic actions
- Serotonin syndrome
- Side effects – abdominal pain, diarrhoea, sweats, tachycardia, HTN, myoclonus, irritability, delirum. Maybe even hyperpyrexia, cardiovascular shock and death
What is the most commonly used class of antidepressants?
SSRIs
Drugs - SSRIs
- Sertraline
- Fluoxetine (Prozac)
Mechanism - SSRIs
- Block the presynaptic serotonin reuptake
Indications - SSRIs
- Anxiety
- Depression
Side effects - SSRIs
- GI upset
- Sexual dysfunction (30+%)
- Anxiety
- Restlessness
- Nervousness
- Insomnia
- Fatigue or sedation
- Dizziness
- Very little risk of cardiotoxicity in OD
- Can develop a discontinuation syndrome with agitation, nausea, disequilibrium and dysphoria if stopped quickly
- Activation syndrome
- Caused by increase in serotonin
- Symptoms – nausea, increased anxiety, panic and agitation
- Typically lasts 2-10 days
What is activation syndrome caused by?
- Caused by increase in serotonin
What are symptoms of activation syndrome?
- Symptoms – nausea, increased anxiety, panic and agitation
- Typically lasts 2-10 days
Drugs - SNRIs
- Venlafaxine
- Duloxetine
Mechanism - SNRIs
- Inhibit serotonin and noradrenergic reuptake like the TCAs
- But without the antihistamine, antiadrenergic or anticholinergic side effects
Indications - SNRIs
- Depression
- Anxiety
- Possibly neuropathic pain
Drugs - novel antidepressants
- Mirtazapine
Mechanism - novel antidepressants
- 5HT2 and 5HT3 receptor antagonist
Side effects - noval antidepressants
- Increase of serum cholesterol
- Sedating
- Weight gain
What can be done to overcome treatment resistance?
- Combination of antidepressants
- Such as SNRI with Mirtazepine
- Or adjunctive treatment with lithium
- Or adjunctive treatment with atypical antipsychotic
- Such as Quetipaine, Olanzapine or Aripiprazole
- ECT
What is a typical combination of antidepressants to overcome treatment resistance?
- Such as SNRI with Mirtazepine
What are examples of atypical antipsychotis combined with antidepressants to overcome treatment resistance?
- Such as Quetipaine, Olanzapine or Aripiprazole
How is medication used for prophylaxis?
When you treat someone for an episode, continue medication for prophylaxis for future relapse:
- First episode
- Continue for 6 months to year
- Second episode
- Continue for 2 years
- Third episode
- Discuss lifelong
How long should someone be given prophylaxis antidepressants after:
- first episode
- second episode
- third episode
- First episode
- Continue for 6 months to year
- Second episode
- Continue for 2 years
- Third episode
- Discuss lifelong
Describe the pharmacological management of anxiety?
- Serotonergic anti-depressant agents so SSRIs and SNRIs
- Tricyclic Chlomipramine
- Adjunctive treatments mainly anti-psychotics Risperidone or Quetiapine
- Avoid symptomatic relief such as diazepam
What are indications for mood stabilisers?
- Bipolar
- Cyclothymia
- Schizoaffective
What are the different classes of mood stabilisers?
- Lithium
- Anticonvulsants
- Antipsychotics
How do you decide what mood stabiliser to use?
Which one you select depends on what you are treating and side effect profile
Lithium - mechanism
- Not sure completely how it works
Lithium - indications
- Long term prophylaxis for
- Mania
- Depressive episodes
What are some factors predicting a positive response to lithium?
- Prior long-term response or family member with good response
- Classic pure mania
- Mania is followed by depression
What should be done before starting lithium?
-
Before starting
- Baseline U&E and TSH
- In woman, pregnancy test as during first trimester associated with Ebsteins anomaly
- Monitoring
- Steady state achieved after 5 days, check 12 hours after last dose
- Once stable check level 3 months and TSH and creatinine 6 months
- Goal
- Blood level between 0.6-1.2
How is lithium use monitored?
- Before starting
- Baseline U&E and TSH
- In woman, pregnancy test as during first trimester associated with Ebsteins anomaly
-
Monitoring
- Steady state achieved after 5 days, check 12 hours after last dose
- Once stable check level 3 months and TSH and creatinine 6 months
- Goal
- Blood level between 0.6-1.2
What are the goal levels for lithium use?
- Blood level between 0.6-1.2
Lithium - side effects
- GI distress
- Including reduced appetite, nausea/vomiting, diarrhoea
- Most common
- Thyroid abnormalities
- Nonsignificant leukocytosis
- Polyurua/polydipsia secondary to ADH antagonist
- Small number can interstitial renal fibrosis leading to renal failure
- Hair loss, acne
- Reduces seizure threshold, cognitive slowing, intention tremor
- Lithium toxicity
What are the different severities of lithium toxicity?
- Mild
- Levels 1.5-2
- See vomiting, diarrhoea, ataxia, dizziness, slurred speech, nystagmus
- Moderate
- Levels 2-2.5
- See nausea, vomiting, anorexia, blurred vision, clonic limb movements, convulsions, delirium, syncope
- Severe
- >2.5
- Generalised convulsions, oligura and renal failure
What are clinical features of lithium toxicity:
- mild
- moderate
- severe
- Mild
- Levels 1.5-2
- See vomiting, diarrhoea, ataxia, dizziness, slurred speech, nystagmus
- Moderate
- Levels 2-2.5
- See nausea, vomiting, anorexia, blurred vision, clonic limb movements, convulsions, delirium, syncope
- Severe
- >2.5
- Generalised convulsions, oligura and renal failure
What are lithium blood levels for the following severities of lithium toxicity:
- mild
- moderate
- severe
- Mild
- Levels 1.5-2
- See vomiting, diarrhoea, ataxia, dizziness, slurred speech, nystagmus
- Moderate
- Levels 2-2.5
- See nausea, vomiting, anorexia, blurred vision, clonic limb movements, convulsions, delirium, syncope
- Severe
- >2.5
- Generalised convulsions, oligura and renal failure
Anticonvulants - drugs
- Valproic acid (Depakote)
- Carbamazepine (Tegretol)
- Lamotrigine (Lamictal)
Valproic acid - indications
- Mania prophylaxis
- As effective as lithium, not as effective in depression prophylaxis
What are factors predicting a positive response to Valproic acid?
- Rapid cycling patients (F>M)
- Comorbid substance issues
- Mixed patients
- Patients with comorbid anxiety disorders
What should be done before giving Valproic acid?
-
Before
- Baseline LFT, pregnancy test and FBC
- Monitoring
- Steady state achieved after 4 days, check 12 hours after last dose and repeat CBC and LFTs
- Goal
- Target level between 50-125
How is Valproic acid monitored?
- Before
- Baseline LFT, pregnancy test and FBC
-
Monitoring
- Steady state achieved after 4 days, check 12 hours after last dose and repeat CBC and LFTs
- Goal
- Target level between 50-125
What is the target blood level of Valproic acid?
- Before
- Baseline LFT, pregnancy test and FBC
- Monitoring
- Steady state achieved after 4 days, check 12 hours after last dose and repeat CBC and LFTs
-
Goal
- Target level between 50-125
Valproic acid - contraindications
- Woman of child bearing age
Valproic acid - side effects
- Thrombocytopenia and platelet dysfunction
- Nausea, vomiting and weight gain
- Sedation, tremor
- Hair loss
Carbamazepine - indications
- First line treatment for acute mania and mania prophylaxis
- Rapid cyclers and mixed patients
What should be done before giving Carbamazepine?
-
Before
- Baseline LFT, FBC, ECG
- Monitoring
- Steady state achieved after 5 days, check 12 hours after last dose and repeat CBC and LFTs
- Goal
- Target level 4-12mcg/ml
How is Carbamazepine monitored?
- Before
- Baseline LFT, FBC, ECG
-
Monitoring
- Steady state achieved after 5 days, check 12 hours after last dose and repeat CBC and LFTs
- Goal
- Target level 4-12mcg/ml
What is the goal blood level of Carbamazepine?
- Before
- Baseline LFT, FBC, ECG
- Monitoring
- Steady state achieved after 5 days, check 12 hours after last dose and repeat CBC and LFTs
-
Goal
- Target level 4-12mcg/ml
Carbemazepine - side effects
- Rash
- Most common
- Nausea, vomiting, diarrhoea
- Sedation, dizziness, ataxia, confusion
- AV conduction delays
- Aplastic anaemia and agrunocytosis
- Water retention
- Drug-drug interactions
- Check BNF
Lamotrigine - indications
- Similar to other anticonvulsants
- Also used for neuropathic/chronic pain
What should be done before giving lamotrigine and what dose should be used?
- Before
- Baseline LFT
- Initiation
- Start with 25mg daily for 2 weeks then increase to 50mg after 2 weeks then increase to 100mg after 2 weeks
Lamotrigine - side effects
- If titrate up doses to quickly
- Serious rash – toxic epidermal necrolysis and Stevens Johnson’s syndrome
- If any rash develops, discontinue medication immediately
- Nausea/vomiting
- Sedation, dizziness, ataxia, confusion
Lamotrigine - drug interactions
- Drugs that increase Lamotrigine levels
- VPA (doubles concentration so use slower dose titration)
- Sertraline
What antipsychotics can be used as mood stabilisers?
